ConcertAI's TeraRecon, the advanced visualization and clinical AI SaaS company, announced its strategic collaboration with Optellum Ltd (Oxford, UK), a global leader in AI clinical decision support for early lung cancer diagnosis and precision treatment planning. Through this partnership, the Optellum Virtual Nodule Clinic solution will be seamlessly integrated...
AI has become an increasingly valuable tool in the field of biotechnology. Across various sectors like pharmaceuticals, healthcare, animal husbandry, agriculture, and AI and machine learning (ML) technologies are reshaping processes to achieve more precise and efficient outcomes. The integration of AI in biotechnology holds immense potential for driving...
OptimizeRx Corp, the leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, announced it has signed an agreement to acquire Scottsdale, Arizona-based Healthy Offers, Inc., dba Medicx Health ("Medicx”), a leading healthcare consumer-focused omnichannel marketing and analytics company. The transaction...
Former BMS, Pfizer leader to help AI-driven company accelerate its development of novel medicines discovered via its proprietary RNA foundation model
Atomic AI, a biotechnology company fusing cutting-edge machine learning with state-of-the-art structural biology to unlock RNA drug discovery, announced the addition of Manjunath “Manju” Ramarao, Ph.D., as Chief Scientific...
Perimeter Medical Imaging AI, Inc. – a commercial-stage medical technology company – announced that patient randomization is underway at Mayo Clinic in Florida, the most recent clinical site to be initiated as part of an ongoing multi-center, randomized two-arm pivotal clinical trial evaluating the investigational Perimeter B-Series OCT combined...
Bayer AG announced the opening of its first Cell Therapy Launch Facility in Berkeley, California to create the capacity to bring cell therapies to patients on a global scale. The $250 million (USD), 100,000-square-foot facility will supply the material required for late-stage clinical trials and potential commercial launch of...
With Sapio Chemistry's new solution, biopharma companies can unify their research projects and simplify chemical synthesis and registration workflows
Sapio Sciences , the science-aware™ laboratory informatics platform, announced the launch of the Sapio Chemistry solution , bringing together small and large molecule discovery workflows on a single platform. Built on the same...
EMSAR planned for a seamless leadership transition to position their next phase of growth and Dave Elario comes to EMSAR with a rich history of key service leadership in high-profile global organizations.
EMSAR, a leading biomedical services company, is pleased to announce the appointment of Dave Elario as its new Chief Executive Officer (CEO),...
Hyperfine, Inc., the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared portable magnetic resonance brain imaging system—the Swoop® system—announced FDA clearance of updated software. Built on a robust AI foundation, the latest software brings image quality enhancements to the Swoop® system’s diffusion-weighted imaging...
New offering arms life sciences with novel clinical AI to democratize analytics across the organization and drive insights at an unprecedented speed
Mendel, a clinical artificial intelligence technology leader, announced the launch of Hypercube, an AI-copilot that enables life sciences and healthcare enterprises to interrogate their troves of patient data...
